glutathione congestive heart failure Infusion Before and 3 Days After Primary Angioplasty Blunts Ongoing NOX2‐Mediated Inflammatory Response Glutathione system enhancement for cardiac

The pattern is consistent: those who align glutathione intake with days 46 of their injection cycle

Low Level Laser Therapy (LLLT) We use Erchonias FDA-cleared lasers to: Boost mitochondrial ATP production Reduce inflammation and oxidative stress Enhance neural connectivity and brain oxygenation This low-level laser therapy is non-invasive, painless, and kid-friendly

The liver is the primary site of glutathione production

Weeks 8-12: Visible Results This phase typically brings the most noticeable changes

doi: 10.3389/fimmu.2026.1758379 Received 01 December 2025 Revised 05 March 2026 Accepted 05 March 2026 Published 28 April 2026 Volume 17 - 2026 Edited by Varun Sasidharan Nair, Italian Institute of Technology (IIT), Italy Reviewed by Mahmoud Abdelrahman Alkabbani, Egyptian Russian University, Egypt Lingjie Meng, Zunyi Medical University, China Updates Copyright 2026 Sivalingam

Ethics declarations Conflict of interest The authors declare that they have no competing interests